E ¼ As, (0.59 g, 2.0 mmol) in DME (20 ml) at ꢀ50 ꢁC. The
resulting orange solution was warmed to ambient temperature
and stirred overnight in the absence of light. Volatiles were
removed in vacuo and the residue washed with hexane (40
ml) to leave a red powder, which was recrystallised from
DME (5 ml) at ꢀ30 ꢁC to yield 9 as red rods (0.51 g, 67%).
M.p. 118–120 ꢁC (dec.); NMR: 1H (400 MHz, C6D6) d 2.73
(s, 12H, OCH3), 2.99 (s, 8H, OCH2), 7.55–8.33 (m, 20H,
ArH); 13C (101.6 MHz, C6D6) d 59.2 (OCH3), 71.2 (OCH2),
126.2, 127.4, 131.8 (Ar–CH), 148.0 (ipso-C), 238.1 (AsC); IR
(Nujol, u/cmꢀ1) 1642 s, 1598 s; MS APCI: m/z 286.8
[PhC(O)As+, 100], 105 (PhCO+, 65%).
(30 ml), extracted with diethyl ether (50 ml) and filtered; the
filtrate was placed at ꢀ30 ꢁC overnight, yielding 13 as colour-
less crystals (yield 0.18 g, 56% based on proposed InCl dispro-
portionation). M.p. 80 ꢁC (decomp.); NMR: 1H (400 MHz,
C6D6) d 1.10 (s, 18H. But), 1.13 [br, 6H, CH3 (Et2O)] 2.95
[s, 6H, CH3 (DME)], 3.18 [s, 4H, CH2 (DME)], 3.28 [br, 4H,
CH2 (Et2O)]); 13C (101.6 MHz, C6D6) d 15.0 [CH3 (Et2O)],
25.7 [C(CH)3], 52.3 (CMe3), 59.1 [CH3 (DME)], 65.8 [CH2
(Et2O)], 69.8 [CH2 (DME)], 244.9 (AsC); IR (Nujol, u/cmꢀ1
)
AsCO 1693 s, 1675 s; MS APCI: m/z 563 (M+ ꢀ Et2O, 10%).
P[As{C(O)But}2]3 , 14. To a solution of 2 (0.840 g, 2.82
mmol) in DME (50 ml) was added PCl3 (0.082 ml, 0.94 mmol)
at ꢀ78 ꢁC whilst stirring. The resulting yellow solution was
stirred at room temperature for 24 h after which time it had
turned orange. Volatiles were removed in vacuo leaving a yel-
low-orange residue, which was extracted with hexane (3 ꢃ 30
ml). The extract was filtered and place at ꢀ30 ꢁC overnight,
yielding yellow crystals of 14 (0.150 g, 21%). M.p. 184–
186 ꢁC (decomp). NMR: 1H (400 MHz, C6D6) d 1.29 (s,
54H, But); 13C (101.6 MHz, C6D6) d 25.4 [C(CH3], 49.4
[C(CH3)], 225.2 (CO); 31P{1H} (121.7 MHz, C6D6) d ꢀ78.9
(s); IR (Nujol, u/cmꢀ1) 1708 s, 1660 s, 1475 m, 1363 m; MS
APCI: m/z 767.0 (M+, 100); anal. found: C 46.67%, H
7.11%, calcd. for C30H54O6PAs3 : C 47.0%, H 7.05%.
[Na{g2-O,O–OC(Mes*)AsC(Mes*)O}(DME)2], 10. A solu-
tion of Na{N(SiMe3)2} (0.055 g, 0.3 mmol) in DME (20 ml)
was added over 20 min to a solution of the diacylarsane 8,
R ¼ Mes*, E ¼ As, (0.20 g, 0.3 mmol) in DME (20 ml) at
25 ꢁC. The resulting solution was heated at reflux for 3 h after
which time the yellow solution was concentrated in vacuo to 5
ml and placed at ꢀ30 ꢁC overnight to yield 10 as yellow cubic
1
crystals (0.18 g, 71%). M.p. 240–250 ꢁC (dec.); NMR: H (400
MHz, C6D6) d 1.42 (s, 18H, p-But), 1.93 (s, 36H, o-But), 3.18
(s, 8H, OCH2), 3.21 (s, 12H, OCH2CH3), 7.63 (s, 4H, ArH);
13C (101.6 MHz, C6D6) d 30.2, 33.4 (CCH3), 33.4, 37.2
(CCH3), 57.4 (OCH2CH3), 70.0 (OCH2), 121.6 (Ar–CH),
143.7, 146.4, 147.3, (quat. Ar–C), 202.1 (AsC); IR (Nujol, u/
cmꢀ1) 1599 s, 1568 s; MS APCI: m/z 286.8 [Mes*C(O)+,
100%].
P[As{C(O)Ph}2]3 , 15. To a solution of 6 (0.226 g, 0.59
mmol) in DME (50 ml) was added PCl3 (0.017 ml, 0.197 mmol)
at ꢀ78 ꢁC whilst stirring. The resulting yellow solution was
stirred at room temperature for 24 h after which it had turned
orange. Volatiles were removed in vacuo leaving a yellow-
orange residue, which was washed with hexane and extracted
with diethyl ether (3 ꢃ 20 ml). The extract was filtered and
placed at ꢀ30 ꢁC overnight to yield 15 as yellow crystals
[Na{g2-O,O–OC(Mes*)SbC(Mes*)O}(DME)2], 11. A solu-
tion of Na{N(SiMe3)2} (0.10 g, 0.56 mmol) in DME (20 ml)
was added over 20 min to a solution of the diacylstibane 8,
R ¼ Mes*, E ¼ Sb, (0.37 g, 0.56 mmol) in DME (20 ml) at
25 ꢁC. The resulting solution was warmed to room temperature
over 4 h over which time it became a bright pink colour. The
volatiles were remove in vacuo and the resulting pink powder
was extracted with DME (10 ml). This solution was concen-
trated in vacuo to 5 ml and placed at ꢀ30 ꢁC overnight to yield
11 as purple cubic crystals (0.33 g, 68%). M.p. 86–88 ꢁC (dec.);
NMR: 1H (400 MHz, C6D6) d 1.20 (s, 18H, p-But), 1.72 (s,
36H, o-But), 3.04 (s, 8H, OCH2), 3.09 (s, 12H, OCH2CH3),
7.41 (s, 4H, ArH); 13C (101.6 MHz, C6D6) d 30.2, 31.6
(CCH3), 34.0, 37.2 (CCH3), 57.5 (OCH2CH3), 70.0 (OCH2),
121.9 (Ar-CH), 141.5, 146.2, 147.4, (quat. Ar–C), 210.3
(AsC); IR (Nujol, u/cmꢀ1) 1598 s, 1572 s; MS APCI: m/z
286.8 [Mes*C(O)+, 100%]; anal. found C 62.87, H 8.88%, calcd
for C46H78NaO6Sb: C 63.37, H 9.02%.
1
(0.03 g, 18%). M.p. 130–132 ꢁC (dec.). NMR: H (400 MHz,
C6D6) d 6.65–6.75 (m, 12H, m-ArH), 6.85 (t, 6H, p-ArH,
3
3JHH ¼ 8 Hz), 7.85 (d, 12H, o-ArH, JHH ¼ 8 Hz); 13C
(101.6 MHz, C6D6) d 128.9 (m-Ar), 129.3 (o-Ar), 133.7 (p-
Ar), 140.8 (ipso-Ar), 209.9 (AsC); 31P{1H} (121.7 MHz,
C6D6) d ꢀ73.4; IR (Nujol, u/cmꢀ1) 1654.6 s, 1629.0 s, 1460
m, 1444 m; MS APCI: m/z 317.1 [PAs(C(O)Ph)2+, 100],
285.9 [As(C(O)Ph)2 , 45%]; Anal. found: C 55.45%, H 3.41%,
calcd. for C42H30O6PAs3 : C 56.88%, H 3.39%.
t
2
t
t
=
[({PhSeC(Bu ) O}Li{g -O,O–OC(Bu )AsC(Bu )O})2], 16. A
solution of 2 (0.516 g, 1.35 mmol) in DME (30 ml) was added
to a solution of PhSeCl (0.259 g, 1.35 mmol) in DME (20 ml)
at ꢀ78 ꢁC. The resulting yellow solution was allowed to warm
to room temperature and stirred for 24 h. Volatiles were
removed in vacuo leaving an orange oil, which was extracted
with hexane (30 ml), filtered and the filtrate placed at ꢀ30 ꢁC
overnight yielding 16 as yellow-orange crystals (0.05 g, 8%).
[Mg{g2-O,O–OC(Ph)AsC(Ph)O}2(DME)], 12. A solution of
MgBu2 (0.25 mmol) in DME (20 ml) was added over 20 min to
a solution of the diacylarsane 8, R ¼ Ph, E ¼ As, (0.15 g, 0.5
mmol) in DME (20 ml) at ꢀ50 ꢁC. The resulting orange solu-
tion was warmed to ambient temperature and stirred overnight
in the absence of light. Volatiles were removed in vacuo and the
residue washed with hexane (40 ml) to leave a red powder,
which was recrystallised from DME (5 ml) at ꢀ30 ꢁC to yield
12 as red rods (0.11 g, 67%). M.p. 133–137 ꢁC (dec.); NMR:
1H (400 MHz, C6D6) d 2.90 (s, 6H, OCH3CH3), 3.04 (s, 4H,
OCH2), 7.21–8.33 (m, 20H, ArH); 13C (101.6 MHz, C6D6) d
58.0 (OCH3), 69.5 (OCH2), 124.5, 130.9, 132.6 (Ar–CH),
141.0 (ipso-C), 201.1 (AsC); IR (Nujol, u/cmꢀ1) 1548 s, 1524
s; MS APCI: m/z 77 (Ph+, 100), 105 (PhCO+, 50%).
1
M.p. 83–85 ꢁC (dec.). NMR: H (400 MHz, C6D6) d 1.04 (s,
18H, But), 1.30 (s, 36H, But), 7.04–7.49 (m, 8H, ArH); 13C
(100.6 MHz, C6D6)
d 26.7, 28.3 [C(CH3)3], 48.9, 49.6
(CMe3), 126.5 (m-Ar), 128.7 (o-Ar), 129.2 (p-Ar), 136.4 (ipso-
Ar), 208.1 (CO), 264.9 (AsCO); IR (Nujol, u/cmꢀ1) 1701 s,
1635 s, 1568 s, 1460 m, 1378 m; MS APCI: m/z 227
[PhSeC(H)But+, 20%].
Structure determinations
Crystals of 5, 6, 7, 9, 10, 11, 12, 13 and 15 suitable for X-ray
structure determination were mounted in silicone oil. Crystal-
lographic measurements were made using either Nonius
Kappa CCD or Enraf-Nonius CAD4 diffractometers. The
structures were solved by direct methods and refined on F2
by full-matrix least-squares methods (SHELXL9719 or
SHELXL9320) using all unique data. Crystal data, details of
data collections and refinements are given in Table 1. The
[LiCl(Et2O)(DME){g2-O,O–Cl3InAs[C(O)R]2}], 13. A solu-
tion of 2 (0.452 g, 1.52 mmol) in DME (30 ml) was added
dropwise to a suspension of InCl (0.229 g, 1.52 mmol) in
DME–Et2O (50:50, 25 ml) at ꢀ78 ꢁC. The resulting pale yellow
solution was allowed to warm to room temperature and stirred
for 24 h. Volatiles were removed in vacuo leaving indium
deposits and a white powder, which was washed with hexane
New J. Chem., 2003, 27, 466–474
473